Boon Hwa Andre Choo

This inventor holds 11 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignees: Agency for Science, Technology and Research, Immune System Therapeutics Ltd, Singapore Health Services Pte Ltd. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Boon Hwa Andre Choo. Retrieved from https://idiyas.com/inventor/boon-hwa-andre-choo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 3)

% Patents Active = 81.8

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 22(Granted Patents)

Company Filing History:

8 out of 1,561

Agency for Science, Technology and Research

patents

3 out of 3

Immune System Therapeutics Ltd

patents

1 out of 140

Singapore Health Services Pte Ltd

patents

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723088 - ANTIGEN BINDING MOLECULES AND METHODS THEREOF II (2026-09-01),

2. 11512292 - Cytotoxic antibody (2022-11-29),

3. 11306153 - Anti-AXL tyrosine kinase receptor antibodies and uses thereof (2022-04-19),

4. 10428312 - Cytotoxic antibody (2019-10-01),

5. 10287547 - Enrichment and characterization of human corneal endothelial cells (hCENC) with novel monoclonal antibody (2019-05-14),

6. 9334324 - Podocalyxin-like-protein-1 binding antibody molecule (2016-05-10),

7. 8906678 - Use of markers of undifferentiated pluripotent stem cell (2014-12-09),

8. 8802376 - Methods for identifying candidate cytotoxic antibody molecules (2014-08-12),

9. 7838041 - Method for treating multiple myeloma (2010-11-23),

10. 7556803 - Method for treating multiple myeloma (2009-07-07),

11. 7344715 - Method for treating multiple myeloma (2008-03-18),

Title: Boon Hwa Andre Choo: Innovator in Antibody Research

Introduction

Boon Hwa Andre Choo is a prominent inventor based in Singapore, known for his significant contributions to the field of antibody research. He holds a total of 11 patents, showcasing his innovative approach to developing therapeutic solutions.

Latest Patents

Among his latest patents, Choo has developed a cytotoxic antibody that binds to a glycosylated protein. This antibody targets specific glycan motifs, including Fucα1-2Galβ1-3GlcNAcβ1-3Galβ1 and Fucα1-2Galβ1-3GlcNAc. Additionally, he has disclosed antibodies that exhibit cytotoxic effects against undifferentiated pluripotent cells. Another notable invention is the anti-AXL tyrosine kinase receptor antibodies, which are designed to bind to a glycan on the AXL receptor tyrosine kinase. These antigen-binding proteins can be conjugated to a radioisotope or cytotoxin, allowing for internalization into cells upon binding. His work also includes compositions that comprise a physiologically acceptable carrier and a therapeutically effective amount of the antigen-binding protein, along with methods for detecting cancer.

Career Highlights

Choo has worked with esteemed organizations such as the Agency for Science, Technology and Research and Immune System Therapeutics Ltd. His career reflects a commitment to advancing medical research and developing innovative therapeutic strategies.

Collaborations

Choo has collaborated with notable individuals in his field, including Robert Lindsay Raison and Rosanne Dorothy Dunn, who have contributed to his research endeavors.

Conclusion

Boon Hwa Andre Choo's work in antibody research exemplifies innovation and dedication to improving therapeutic options. His patents and collaborations highlight his impact on the scientific community and the potential for future advancements in medicine.

Profile summary based on public USPTO records.